Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2025-12-31 @ 5:07 AM
Study NCT ID:
NCT04739566
Status:
WITHDRAWN
Last Update Posted:
2024-03-25
First Post:
2021-01-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dabrafenib and Trametinib Combination as a Neoadjuvant Strategy in BRAF-positive Anaplastic Thyroid Cancer
Sponsor:
Saint Petersburg State University, Russia
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-22
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-29
First Submit QC Date:
None
Study First Post Date:
2021-02-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-21
Last Update Post Date:
2024-03-25
Last Update Post Date Type:
ACTUAL